jazz pharma  bui gw pharma  72 billion ad cannabibase drug  portfolio
reuter  jazz pharmaceut plc said  wednesdai   agre  bui gw pharmaceut plc   72 billion cashstock deal   bolster  neurosci busi   addit   cannabibase epilepsi treatment
